z-logo
Premium
A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis
Author(s) -
Naik Haley,
Lockwood Stephen,
Saavedra Arturo
Publication year - 2017
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.12986
Subject(s) - medicine , toxic epidermal necrolysis , cd8 , stage (stratigraphy) , graft versus host disease , pathology , erythroderma , retrospective cohort study , dermatology , gastroenterology , disease , immunology , immune system , biology , paleontology
Background Stage 4 skin graft‐versus‐host disease (GVHD) is associated with poor prognosis and high mortality rates. Clinical and histologic similarities with toxic epidermal necrolysis (TEN) make it difficult to distinguish between these 2 life‐threatening conditions. Methods A retrospective cohort study was conducted from a tertiary referral center. Skin biopsies were obtained from 11 patients who developed stage 4 skin GVHD and 11 patients who developed TEN between 2005 and 2012. The CD8+/CD4+ T lymphocyte ratios were assessed in lesional skin specimens. Results Average CD8+and CD4+ cell counts co‐expressing CD3 were 126.29 (range 86.42‐173.06) and 84.60 (29.87‐197.20) for stage 4 skin GVHD patients, and 61.97 (45.79‐146.67) and 7.65 (0.00‐39.50) for TEN patients, respectively. Immunohistochemical studies of stage 4 skin GVHD and TEN skin demonstrated average CD8+/CD4+ ratios of 1.78 (range 0.69‐3.09) and 7.33 (1.16‐12.3), respectively ( P = .013). Conclusions Stage 4 skin GVHD and TEN are processes with cytotoxic profiles. TEN is notable for a greater relative depletion of CD4+ T lymphocytes compared with stage 4 skin GVHD, while stage 4 skin GVHD tends to be more inflammatory than TEN. These data suggest an immunohistologic method by which these 2 entities may be distinguished.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom